Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 3/20 | 0.46 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | MMP1 | P03956 | 1/20 | 0.38 |
| ▸ | MMP13 | P45452 | 1/20 | 0.38 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28295296 | 0.78 | NPC1 (0.48) | RAB9ANPC1KMT2AMEN1HCRTR2 | |
| SCHEMBL16681985 | 0.70 | GAA (0.46) | RAB9ANPC1CNR2KMT2AMEN1 | |
| SCHEMBL18041029 | 0.70 | GAA (0.46) | RAB9ANPC1CNR2KMT2AMEN1 | |
| SCHEMBL9179644 | 0.67 | NPC1 (0.43) | RAB9ANPC1KMT2AMMP1MMP13 | |
| SCHEMBL12204033 | 0.66 | NPY5R (0.54) | NPY5RMAOBRAB9ANPC1TSHR | |
| Phenetole SCHEMBL8814811 | 0.65 | LTA4H (0.49) | CNR2KMT2AMEN1MAPT | |
| SCHEMBL20943573 | 0.65 | MAOB (0.72) | MAOB | |
| SCHEMBL20943570 | 0.65 | MAOB (0.72) | MAOB | |
| SCHEMBL255811 | 0.65 | ACACB (0.81) | ACACBMAOB | |
| SCHEMBL255798 | 0.65 | ACACB (0.81) | ACACBMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3060554-A1 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | Bristol-Myers Squibb Company (US) | 2016-08-31 | — | — | EP | disclosed |
| WO-2015061518-A1 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | BRISTOL-MYERS SQUIBB COMPANY (US) | 2015-04-30 | — | — | WO | disclosed |